These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 29018074)
21. Pharmacy ownership in Canada: implications for the authority and autonomy of community pharmacy managers. Dobson RT; Perepelkin J Res Social Adm Pharm; 2011 Dec; 7(4):347-58. PubMed ID: 21272538 [TBL] [Abstract][Full Text] [Related]
22. Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data. Winslade N; Tamblyn R BMJ Open; 2017 Sep; 7(9):e015877. PubMed ID: 28939571 [TBL] [Abstract][Full Text] [Related]
23. Prevalence and characteristics of pharmacies owned and operated by schools of pharmacy in the United States. Nathan JP; Grossman S; Zerilli T; Pace A Curr Pharm Teach Learn; 2018 Feb; 10(2):159-164. PubMed ID: 29706270 [TBL] [Abstract][Full Text] [Related]
24. Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR). Latif A; Boardman HF; Pollock K Res Social Adm Pharm; 2013; 9(6):949-57. PubMed ID: 23506650 [TBL] [Abstract][Full Text] [Related]
25. A cross-sectional national survey of community pharmacy staff: Knowledge and antibiotic provision. Zawahir S; Lekamwasam S; Aslani P PLoS One; 2019; 14(4):e0215484. PubMed ID: 31022197 [TBL] [Abstract][Full Text] [Related]
26. Community pharmacy in the United Arab Emirates: characteristics and workforce issues. Hasan S; Sulieman H; Chapman C; Stewart K; Kong DC Int J Pharm Pract; 2011 Dec; 19(6):392-9. PubMed ID: 22060234 [TBL] [Abstract][Full Text] [Related]
27. Influence of strategic planning on product marketing and health service orientation of community pharmacies-A national survey in Finland. Jokinen L; Puumalainen I; Airaksinen M Health Policy; 2019 May; 123(5):462-467. PubMed ID: 30808534 [TBL] [Abstract][Full Text] [Related]
28. Primary health care policy and vision for community pharmacy and pharmacists in England. Anderson C; Sharma R Pharm Pract (Granada); 2020; 18(1):1870. PubMed ID: 32256901 [TBL] [Abstract][Full Text] [Related]
29. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies. MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792 [TBL] [Abstract][Full Text] [Related]
30. Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development. Matheson C; Thiruvothiyur M; Robertson H; Bond C Int J Drug Policy; 2016 Jan; 27():105-12. PubMed ID: 26723885 [TBL] [Abstract][Full Text] [Related]
31. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007. Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471 [TBL] [Abstract][Full Text] [Related]
32. Exploring the impact of evolving health policy on independent pharmacy ownership in England. Gidman W Pharm World Sci; 2010 Aug; 32(4):488-95. PubMed ID: 20454857 [TBL] [Abstract][Full Text] [Related]
33. Children's toothache is becoming everybody's business: where do parents go when their children have oral pain in London, England? A cross-sectional analysis. Muirhead VE; Quayyum Z; Markey D; Weston-Price S; Kimber A; Rouse W; Pine CM BMJ Open; 2018 Feb; 8(2):e020771. PubMed ID: 29490969 [TBL] [Abstract][Full Text] [Related]
34. How youth-friendly are pharmacies in New Zealand? Surveying aspects of accessibility and the pharmacy environment using a youth participatory approach. Horsfield E; Kelly F; Clark T; Sheridan J Res Social Adm Pharm; 2014; 10(3):529-38. PubMed ID: 23981912 [TBL] [Abstract][Full Text] [Related]
35. Mapping pharmacy deserts and determining accessibility to community pharmacy services for elderly enrolled in a State Pharmaceutical Assistance Program. Pednekar P; Peterson A PLoS One; 2018; 13(6):e0198173. PubMed ID: 29864159 [TBL] [Abstract][Full Text] [Related]
36. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies. McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303 [TBL] [Abstract][Full Text] [Related]
37. Supporting the provision of pharmacy medication reviews to marginalised (medically underserved) groups: a before/after questionnaire study investigating the impact of a patient-professional co-produced digital educational intervention. Latif A; Waring J; Chen LC; Pollock K; Solomon J; Gulzar N; Gulzar S; Anderson E; Choudhary S; Abbasi N; Wharrad HJ; Anderson C BMJ Open; 2019 Sep; 9(9):e031548. PubMed ID: 31530620 [TBL] [Abstract][Full Text] [Related]
38. Community pharmacy practice in China: past, present and future. Fang Y; Yang S; Zhou S; Jiang M; Liu J Int J Clin Pharm; 2013 Aug; 35(4):520-8. PubMed ID: 23661172 [TBL] [Abstract][Full Text] [Related]
39. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama. Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165 [TBL] [Abstract][Full Text] [Related]
40. Examination of England's New Medicine Service (NMS) of complex health care interventions in community pharmacy. Latif A; Waring J; Watmough D; Barber N; Chuter A; Davies J; Salema NE; Boyd MJ; Elliott RA Res Social Adm Pharm; 2016; 12(6):966-989. PubMed ID: 26806858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]